The timing really sucks. Why couldn't they wait until BIO CEO's meeting done?
Why at $0.87 ????????
After these statements non long ago??
The US market opportunity for the DIC indication is estimated to be $2 - 3 billion.
Discussions with potential partners for the commercialization and further development of ATryn® in the US have continued through the end of 2007. GTC is planning to conclude an agreement during the first quarter of 2008.
I was brought up to take a MANby his word - otherwise, what is CHARACTER?
from 2Q07 CC:
Dr. Cox -
>The risk profile of GTC's product portfolio is significantly lower than that of the vast majority of biotechnology companies [#msg-20965937].
We share your frustration that the value we have created and continue to create is not yet being recognized in our share price. However, we believe that we have a clear and coherent strategy for success and this will be recognized as we execute on this strategy.
Our opportunity for news flow over the coming months is strong and I greatly look forward to updating you on our progress in future calls.<
You can sue anybody for anything but is it worth it??
5 Reasons not to sue
1 guess you did not read the "Safe Harbor" disclaimer attached to all statements 2 have to deal with law firms like Milberg-Weis it will take years before the stench clears 3 you have to prove fraud (ie intent) since Cox probably owns more shares ttan you do,, that could be tough. 4 If you are successful (highly unlikely) you will be lucky to get 10% on your Loses as the game is rigged and all those meetings Mil-Weiss is holding in 5 star Manhattan restaurants are fairly expensive. 5 you only think you can run the company better than Cox, you do not know that.
Market Data 
Markets 
AI
